✨ 6 results found - Searched 22785 records in 4ms.
Tesis
Kesintasan Pada Kanker Paru Karsinoma Bukan Sel Kecil Jenis Adenokarsinoma Dengan Mutasi Epidermal Growth Factor Receptor Yang Diterapi Dengan Tyrosin Kinase Inhibitor Selama ≥ 18 Bulan Dan Faktor-Faktor Yang Memengaruhinya Di Rumah Sakit Umum Pusat Persahabatan
2024 | BY Vira Weldimira - Sita Laksmi Andarini - Jamal Zaini- Survival in non-small cell carcinoma lung cancer of adenocarcinoma type with epidermal growth factor receptor mutation treated with tyrosine kinase inhibitors for ≥ 18 months and influencing factors at RSUP Persahabatan.
- Nomor Panggil T24614fk
Tesis
Analisis terapi afatinib pada adenokarsinoma paru dengan mutasi epidermal growth factor receptor (EGFR) di RSUP Persahabatan
2023 | BY Widya Angasreni - Sita Laksmi Andarini - Jamal Zaini- Therapy Analysis of afatinib in lung adenocarcinoma with epidermal growth factor receptor mutation (EGFR) at Persahabatan Hospital.
- Nomor Panggil T23185fk
Tesis
Efikasi Gefitinib Dan Erlotinib Pada Pasien Adenokarsinoma Paru Dengan Mutasi Gen Epidermal Growth Factor Receptor Di Rumah Sakit Rujukan Respirasi Nasional Persahabatan Jakarta.
2019 | BY Jamal Zaini - Elisna Syahruddin - Muhammad Ali Asdar- Efficacy of Gefitinib and Erlotinib for Lung Adenocarcinoma with Epidermal Growth Factor Receptor Mutation in Persahabatan Hospital Jakarta, Indonesia.
- Nomor Panggil T19547fk
Tesis
Profil dan Angka Tahan Hidup 1 tahun Kanker Paru Bukan Sel Kecil (KPKBSK) Jenis Adenokarsinoma Paru dengan Mutasi Epidermal Growth Factor Receptor (EGFR) Exon 20 T790M Primer di RSUP Persahabatan
2018 | BY Hapsari Retno Dewanti - Sita Laksmi Andarini - Jamal Zaini- The Characteristics and One Year Survival of Lung Adenocarcinoma Patients with Primary Exon 20 T790M Epidermal Growth Factor Receptor Mutation Treated at Persahabatan Hospital Jakarta, Indonesia.
- Nomor Panggil T18468fk
Tesis
Peran quiescent lung cancer stem cell (CSC) dalam proses resistans terhadap agen epidermal growth factor receptortyrosine kinase inhibitor (EGFR-TKI) pada adenokarsinoma paru dengan mutasi EGFR positif
2020 | BY Moulid Hidayat - Sita Laksmi Andarini - Fumiyuki Takahashi- Role of quiescent lung cancer stem cells in epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR- TKI) resistance in EGFR-mutant lung adenocarcinoma.
- Nomor Panggil T20481fk
Tesis
Peran interleukin 1 alpha dalam mekanisme resitansi terhadap osimertinib pada adenokarsinoma paru
2024 | BY Wira Winardi - Kazuhisa Takahashi - Sita Laksmi Andarini - Fariz Nurwidya- The Role of interleukin 1 alpha in resitant mechanism to osimertinib in lung adenocarcinoma.
- Nomor Panggil T24616fk